Tumor Inflammation-Associated Neurotoxicity Masquerading as Severe Immune Effector Cell-Associated Neurotoxicity Syndrome in a Patient With SCLC Treated With Tarlatamab: A Case Report. - Torasawa M; Shukuya T; Huang J; Nagai R; Ayame N; Arai Y; Hayakawa D; Hayashi T; Nagaoka T; Takahashi K (Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2026)